We hope to see you again soon!

You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.

UK-NOTPR-1010 | April 2022

Continue

Cancel

This is Lundbeck

As a specialist pharmaceutical company, we are tirelessly dedicated to helping to restore brain health, so every person can be their best.

About Us

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialised some of the world’s most widely prescribed therapies for brain diseases.

Our Science

Helping to improve life for patients living with brain diseases  

At Lundbeck we see patients as people and are committed to supporting the person behind the disease.

Our focus

Our sustainability strategy

Through our sustainability strategy, we mitigate business risks, reduce negative impacts, and addresss societal challenges where possible. We remain committed to seven of the 17 UN Sustainable Development Goals.

Read more

Clinical Trials

Lundbeck registers clinical trial protocols and discloses the results of clinical trials, regardless of outcome, in a publicly accessible clinical trial registry ClinicalTrials.gov.

Learn More

Lundbeck at a glance

UK-NOTPR-2202| October 2024